Search research articles
Contact Us
Filters
Showing results (681-690 of 770) with videos related to
Page
of 77
Sort By:
Journal of Colloid and Interface Science
|
May 4, 2020
How does substrate hydrophobicity affect the morphological features of reconstituted wax films and their interactions with nonionic surfactant and pesticide?
Xuzhi Hu, Elias Pambou, Haoning Gong, et al.
Anti-Cancer Drugs
|
January 24, 2018
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer
Chandrasekar Durairaj, Ana Ruiz-Garcia, Eric R Gauthier, et al.
The Breast Journal
|
August 27, 2019
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
Karen A Gelmon, Massimo Cristofanilli, Hope S Rugo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 21, 2014
Oligodendrocyte precursor cell-intrinsic effect of Rheb1 controls differentiation and mediates mTORC1-dependent myelination in brain
Yi Zou, Wanxiang Jiang, Jianqing Wang, et al.
The Review of Scientific Instruments
|
March 3, 2010
The deuteron injector progress of the Peking University Neutron Imaging Facility project
H T Ren, S X Peng, M Zhang, et al.
The Review of Scientific Instruments
|
March 3, 2010
Upgrade of the extraction system of permanent magnet electron cyclotron resonance ion source
M Zhang, S X Peng, H T Ren, et al.
The New England Journal of Medicine
|
December 14, 2016
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S Finn, Miguel Martin, Hope S Rugo, et al.
International Journal of Clinical Oncology
|
December 6, 2018
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients
Hirofumi Mukai, Chikako Shimizu, Norikazu Masuda, et al.
Breast Cancer Research and Treatment
|
January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
H S Rugo, R S Finn, V Diéras, et al.
The Journal of International Medical Research
|
May 23, 2012
The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma
C T Zhang, R Lu, Y L Lin, et al.
Page
of 77
Search research articles
Search
Showing results (681-690 of 770) with videos related to
Sort By:
Page
of 77
Journal of Colloid and Interface Science
|
May 4, 2020
How does substrate hydrophobicity affect the morphological features of reconstituted wax films and their interactions with nonionic surfactant and pesticide?
Xuzhi Hu, Elias Pambou, Haoning Gong, et al.
Anti-Cancer Drugs
|
January 24, 2018
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer
Chandrasekar Durairaj, Ana Ruiz-Garcia, Eric R Gauthier, et al.
The Breast Journal
|
August 27, 2019
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
Karen A Gelmon, Massimo Cristofanilli, Hope S Rugo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 21, 2014
Oligodendrocyte precursor cell-intrinsic effect of Rheb1 controls differentiation and mediates mTORC1-dependent myelination in brain
Yi Zou, Wanxiang Jiang, Jianqing Wang, et al.
The Review of Scientific Instruments
|
March 3, 2010
The deuteron injector progress of the Peking University Neutron Imaging Facility project
H T Ren, S X Peng, M Zhang, et al.
The Review of Scientific Instruments
|
March 3, 2010
Upgrade of the extraction system of permanent magnet electron cyclotron resonance ion source
M Zhang, S X Peng, H T Ren, et al.
The New England Journal of Medicine
|
December 14, 2016
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S Finn, Miguel Martin, Hope S Rugo, et al.
International Journal of Clinical Oncology
|
December 6, 2018
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients
Hirofumi Mukai, Chikako Shimizu, Norikazu Masuda, et al.
Breast Cancer Research and Treatment
|
January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
H S Rugo, R S Finn, V Diéras, et al.
The Journal of International Medical Research
|
May 23, 2012
The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma
C T Zhang, R Lu, Y L Lin, et al.
Page
of 77